MedPath

eRAPID cognitive interview study

Not Applicable
Completed
Conditions
Colorectal Cancer, breast cancer, gynaecological cancer, renal cancer, lung cancer
Cancer
Malignant neoplasms of independent (primary) multiple sites
Registration Number
ISRCTN58893387
Lead Sponsor
niversity of Leeds (UK)
Brief Summary

2016 Results article in https://www.ncbi.nlm.nih.gov/pubmed/27551774 results

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Undergoing chemotherapy and biological treatment with curative or palliative intent
2. Able and willing to give informed consent
3. Have gynaecological, breast, lung, renal and colorectal cancer
4. Male or female
5. Lower Age Limit 18 years

Exclusion Criteria

1. If taking part in other studies run by the group
2. If not able to read and understand English
3. If exhibiting overt psychopathology or serious cognitive dysfunction which would impede their being able to take part in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A bank of adverse event items
Secondary Outcome Measures
NameTimeMethod
o secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath